An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms - A Prospective, Multicenter, Open Label, Single Arm, Intervention Study to Assess Efficacy and Safety of an At-home, Game-based Digital Therapy for Treating Clinical Symptoms of Adult Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)

Lumos Labs, Inc.5 个研究点分布在 1 个国家目标入组 194 人2023年4月15日

适应症ADHD

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: ADHD
发起方: Lumos Labs, Inc.
入组人数: 194
试验地点: 5
主要终点: Conners' Adult ADHD Rating Scales-Investigator Rated: Long Version (CAARS-Inv:L) Inattentive Symptoms subscale
状态: 进行中（未招募）
最后更新: 去年

概览研究者入排标准结局指标研究点相似试验

概览

简要总结

The objective of this study is to assess the safety and effectiveness of an at-home, game-based digital therapy for treating adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD).

注册库

clinicaltrials.gov

开始日期

2023年4月15日

结束日期

2025年6月

最后更新

去年

研究类型

Interventional

研究设计

Single Group

性别

All

研究者

发起方

Lumos Labs, Inc.

责任方

Sponsor

入排标准

入选标准

•22-55 years of age (Cohort I) or 18-21 years of age (Cohort II)
•Confirmed ADHD diagnosis, combined or inattentive type, at Screening based on DSM-5 criteria and established via the MINI-Adult, administered by a trained clinician
•Baseline total score on the DSM 5 Inattentive Symptoms, DSM 5 Hyperactive - Impulsive Symptoms and ADHD Index subscales of the Conners' Adult ADHD Rating Scales-Investigator Rated: Long Version (CAARS-Inv:L) ≥24
•Current, stable use of an FDA approved pharmacological treatment for ADHD for at least 4 weeks prior to screening, but ADHD condition inadequately managed by that medication
•Ability to understand and speak English, follow written and verbal instructions (English), as assessed by the PI and/or Study Coordinator, and give informed consent (English)
•Have ability to connect wireless devices to a functional wireless network daily
•Have access to a computer or smart device (e.g., phone, tablet) with internet access and a Google Chrome web browser
•Ability to comply with all the testing and study requirements

排除标准

•Unstable/uncontrolled, comorbid psychiatric diagnosis, based on clinical interviewing, with significant current active symptoms including but not limited to posttraumatic stress disorder, schizophrenia spectrum and other psychotic disorders, bipolar disorder, autism spectrum disorder, severe obsessive-compulsive disorder, severe depressive or severe anxiety disorder, conduct disorder, or other symptomatic manifestations that in the opinion of the Investigator may confound study data/assessments
•Inadequate IQ to participate in the study as estimated by Investigator (i.e., inability to read/understand the informed consent; inability to understand how the device and therapy (games) work)
•PHQ-9 scores ≥16
•Have previously been assessed by TOVA for potential enrollment in a clinical trial.
•Have previously used a videogame-like digital therapy (e.g., Akili EndeavorRxTM) OR within the last three years, have used a cognitive or brain training platform (e.g., Peak, Brain HQ, Lumosity, Atentiv) for more than two weeks duration
•Known sensitivity to playing video games, such as headaches, dizziness, nausea
•Initiation within the last 4 weeks of behavioral therapy or neurofeedback, or planned initiation during the study. Patients who have been in behavior therapy or neurofeedback consistently for more than 4 weeks may participate provided their routine is unchanged during the course of the study. Patients planning on changing or initiating behavior therapy or neurofeedback during the course of the study will be excluded
•Patient is currently considered a suicide risk in the opinion of the Investigator, as measured by C-SSRS at screening (i.e., score of 4 or 5 on C-SSRS)
•Motor condition (e.g., physical deformity of the hands/arms; protheses) that prevents game playing as observed by the Investigator
•Recent history (within the past 12 months) of suspected alcohol or substance abuse or dependence

结局指标

主要结局

Conners' Adult ADHD Rating Scales-Investigator Rated: Long Version (CAARS-Inv:L) Inattentive Symptoms subscale

时间窗: Study Day 0 to Study Day 63

The Conners' Adult ADHD Rating Scales-Investigator Rated: Long Version (CAARS-Inv:L) has 66 items with multiple subscales.

次要结局

Conners' Adult ADHD Rating Scales-Investigator Rated: Long Version (CAARS-Inv:L) ADHD Symptoms Total subscale(Study Day 0 to Study Day 63)
Adult ADHD Self-Report Scale (ASRS) Inattentive Symptoms Subscale(Study Day 0 to Study Day 63)
Sheehan Disability Scale (SDS)(Study Day 0 to Study Day 63)